Viable tissue in an area of severely reduced perfusion demonstrated with I-123 iomazenil brain SPECT imaging of benzodiazepine receptors

Clinical Nuclear Medicine

Volumn 24, Issue 8, 1999, Pages 576-578

  Hayashida, Kohei ^a,b   Fukuchi, Kazuki ^a   Hasegawa, Yasuhiro ^a   Kume, Norihiko ^a   Cho, Ihn Ho ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Benzodiazepine receptor; I 123 iomazenil brain SPECT; Misery perfusion; Positron emission tomography; Viability

Indexed keywords

ACETAZOLAMIDE; BENZODIAZEPINE RECEPTOR; IODINE 123; IOFETAMINE I 123; IOMAZENIL;

AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HEMIPARESIS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETAZOLAMIDE; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; BRAIN; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CEREBROVASCULAR CIRCULATION; FEMALE; FLUMAZENIL; HUMANS; IODINE RADIOISOTOPES; OXYGEN CONSUMPTION; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032792748     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199908000-00006     Document Type: Article

References (8)

1. Powers W, Grubb R, Raichle M: Physiologic responses to focal cerebral ischemia in humans. Ann Neurol 16:546, 1984.
2. Hirano T, Minematsu K, Hasegawa Y, et al: Acetazolamide reactivity on I-123 I MP single photon emission computed tomography in patients with major cerebral artery occlusive disease: Correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 14:763, 1994.
3. Hayashida K, Miyake Y, Hirose Y, et al: Reduction of I-123 iomazenil uptake in the haemodynamically and metabolically impaired cerebral areas in patients with cerebrovascular disease. Nucl Med Commun 17:701, 1996.
4. Frackowiak R, Lenzi G, Jones T, et al: Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using O-15 and positron emission tomography: Theory, procedure, and normal values. J Comput Assist Tome 4:727, 1980.
5. Hayashida K, Hirose Y, Tanaka Y, et al: Vasoreactive effect of acetazolamide as a function of time with sequential PET O-15 water measurement. Nucl Med Commun 17:1047, 1996.
6. Baron JC: Positron emission tomography studies in ischemic stroke. In: Barnett H, Mohr J, Stein B, Yatsu F, eds. Stroke Pathophysiology, Diagnosis, and Management, 2nd ed. New York: Churchill Livingstone, 1992.
7. Heiss WD, Graf R, Fujita T, et al: Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 28:2045, 1997.
8. Onishi Y, Yonekura Y, Tanaka F, et al: Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: The optimal scan time. Eur J Nucl Med 23:1491, 1996.